Meningococcal Infections Vaccine Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Quadrivalent (Serogroups A, C, W-135, and Y)
1.2.3 Bivalent (Serogroups C and Y)
1.2.4 Serogroup A
1.2.5 Serogroup B
1.2.6 Serogroup X
1.3 Market by Application
1.3.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Infections Vaccine Market Perspective (2017-2028)
2.2 Meningococcal Infections Vaccine Growth Trends by Region
2.2.1 Meningococcal Infections Vaccine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Meningococcal Infections Vaccine Historic Market Size by Region (2017-2022)
2.2.3 Meningococcal Infections Vaccine Forecasted Market Size by Region (2023-2028)
2.3 Meningococcal Infections Vaccine Market Dynamics
2.3.1 Meningococcal Infections Vaccine Industry Trends
2.3.2 Meningococcal Infections Vaccine Market Drivers
2.3.3 Meningococcal Infections Vaccine Market Challenges
2.3.4 Meningococcal Infections Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Infections Vaccine Players by Revenue
3.1.1 Global Top Meningococcal Infections Vaccine Players by Revenue (2017-2022)
3.1.2 Global Meningococcal Infections Vaccine Revenue Market Share by Players (2017-2022)
3.2 Global Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Meningococcal Infections Vaccine Revenue
3.4 Global Meningococcal Infections Vaccine Market Concentration Ratio
3.4.1 Global Meningococcal Infections Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Infections Vaccine Revenue in 2021
3.5 Meningococcal Infections Vaccine Key Players Head office and Area Served
3.6 Key Players Meningococcal Infections Vaccine Product Solution and Service
3.7 Date of Enter into Meningococcal Infections Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Meningococcal Infections Vaccine Breakdown Data by Type
4.1 Global Meningococcal Infections Vaccine Historic Market Size by Type (2017-2022)
4.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2023-2028)
5 Meningococcal Infections Vaccine Breakdown Data by Application
5.1 Global Meningococcal Infections Vaccine Historic Market Size by Application (2017-2022)
5.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Meningococcal Infections Vaccine Market Size (2017-2028)
6.2 North America Meningococcal Infections Vaccine Market Size by Type
6.2.1 North America Meningococcal Infections Vaccine Market Size by Type (2017-2022)
6.2.2 North America Meningococcal Infections Vaccine Market Size by Type (2023-2028)
6.2.3 North America Meningococcal Infections Vaccine Market Share by Type (2017-2028)
6.3 North America Meningococcal Infections Vaccine Market Size by Application
6.3.1 North America Meningococcal Infections Vaccine Market Size by Application (2017-2022)
6.3.2 North America Meningococcal Infections Vaccine Market Size by Application (2023-2028)
6.3.3 North America Meningococcal Infections Vaccine Market Share by Application (2017-2028)
6.4 North America Meningococcal Infections Vaccine Market Size by Country
6.4.1 North America Meningococcal Infections Vaccine Market Size by Country (2017-2022)
6.4.2 North America Meningococcal Infections Vaccine Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Meningococcal Infections Vaccine Market Size (2017-2028)
7.2 Europe Meningococcal Infections Vaccine Market Size by Type
7.2.1 Europe Meningococcal Infections Vaccine Market Size by Type (2017-2022)
7.2.2 Europe Meningococcal Infections Vaccine Market Size by Type (2023-2028)
7.2.3 Europe Meningococcal Infections Vaccine Market Share by Type (2017-2028)
7.3 Europe Meningococcal Infections Vaccine Market Size by Application
7.3.1 Europe Meningococcal Infections Vaccine Market Size by Application (2017-2022)
7.3.2 Europe Meningococcal Infections Vaccine Market Size by Application (2023-2028)
7.3.3 Europe Meningococcal Infections Vaccine Market Share by Application (2017-2028)
7.4 Europe Meningococcal Infections Vaccine Market Size by Country
7.4.1 Europe Meningococcal Infections Vaccine Market Size by Country (2017-2022)
7.4.2 Europe Meningococcal Infections Vaccine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Infections Vaccine Market Size (2017-2028)
8.2 Asia-Pacific Meningococcal Infections Vaccine Market Size by Type
8.2.1 Asia-Pacific Meningococcal Infections Vaccine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Meningococcal Infections Vaccine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Meningococcal Infections Vaccine Market Share by Type (2017-2028)
8.3 Asia-Pacific Meningococcal Infections Vaccine Market Size by Application
8.3.1 Asia-Pacific Meningococcal Infections Vaccine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Meningococcal Infections Vaccine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Meningococcal Infections Vaccine Market Share by Application (2017-2028)
8.4 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region
8.4.1 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Meningococcal Infections Vaccine Market Size (2017-2028)
9.2 Latin America Meningococcal Infections Vaccine Market Size by Type
9.2.1 Latin America Meningococcal Infections Vaccine Market Size by Type (2017-2022)
9.2.2 Latin America Meningococcal Infections Vaccine Market Size by Type (2023-2028)
9.2.3 Latin America Meningococcal Infections Vaccine Market Share by Type (2017-2028)
9.3 Latin America Meningococcal Infections Vaccine Market Size by Application
9.3.1 Latin America Meningococcal Infections Vaccine Market Size by Application (2017-2022)
9.3.2 Latin America Meningococcal Infections Vaccine Market Size by Application (2023-2028)
9.3.3 Latin America Meningococcal Infections Vaccine Market Share by Application (2017-2028)
9.4 Latin America Meningococcal Infections Vaccine Market Size by Country
9.4.1 Latin America Meningococcal Infections Vaccine Market Size by Country (2017-2022)
9.4.2 Latin America Meningococcal Infections Vaccine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Infections Vaccine Market Size (2017-2028)
10.2 Middle East & Africa Meningococcal Infections Vaccine Market Size by Type
10.2.1 Middle East & Africa Meningococcal Infections Vaccine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Meningococcal Infections Vaccine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Meningococcal Infections Vaccine Market Share by Type (2017-2028)
10.3 Middle East & Africa Meningococcal Infections Vaccine Market Size by Application
10.3.1 Middle East & Africa Meningococcal Infections Vaccine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Meningococcal Infections Vaccine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Meningococcal Infections Vaccine Market Share by Application (2017-2028)
10.4 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country
10.4.1 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Creative Biolabs(USA)
11.1.1 Creative Biolabs(USA) Company Details
11.1.2 Creative Biolabs(USA) Business Overview
11.1.3 Creative Biolabs(USA) Meningococcal Infections Vaccine Introduction
11.1.4 Creative Biolabs(USA) Revenue in Meningococcal Infections Vaccine Business (2017-2022)
11.1.5 Creative Biolabs(USA) Recent Developments
11.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India)
11.2.1 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Company Details
11.2.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Business Overview
11.2.3 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Introduction
11.2.4 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Revenue in Meningococcal Infections Vaccine Business (2017-2022)
11.2.5 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Meningococcal Infections Vaccine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Quadrivalent (Serogroups A, C, W-135, and Y)
Table 3. Key Players of Bivalent (Serogroups C and Y)
Table 4. Key Players of Serogroup A
Table 5. Key Players of Serogroup B
Table 6. Key Players of Serogroup X
Table 7. Global Meningococcal Infections Vaccine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Meningococcal Infections Vaccine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Meningococcal Infections Vaccine Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Meningococcal Infections Vaccine Market Share by Region (2017-2022)
Table 11. Global Meningococcal Infections Vaccine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Meningococcal Infections Vaccine Market Share by Region (2023-2028)
Table 13. Meningococcal Infections Vaccine Market Trends
Table 14. Meningococcal Infections Vaccine Market Drivers
Table 15. Meningococcal Infections Vaccine Market Challenges
Table 16. Meningococcal Infections Vaccine Market Restraints
Table 17. Global Meningococcal Infections Vaccine Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Meningococcal Infections Vaccine Revenue Share by Players (2017-2022)
Table 19. Global Top Meningococcal Infections Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2021)
Table 20. Ranking of Global Top Meningococcal Infections Vaccine Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Meningococcal Infections Vaccine Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Meningococcal Infections Vaccine Product Solution and Service
Table 24. Date of Enter into Meningococcal Infections Vaccine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Infections Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2017-2022)
Table 28. Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2023-2028)
Table 30. Global Meningococcal Infections Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Meningococcal Infections Vaccine Revenue Share by Application (2017-2022)
Table 32. Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Meningococcal Infections Vaccine Revenue Share by Application (2023-2028)
Table 34. North America Meningococcal Infections Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Meningococcal Infections Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Meningococcal Infections Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Meningococcal Infections Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Meningococcal Infections Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Meningococcal Infections Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Meningococcal Infections Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Meningococcal Infections Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Meningococcal Infections Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Meningococcal Infections Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Meningococcal Infections Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Meningococcal Infections Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Meningococcal Infections Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Meningococcal Infections Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Meningococcal Infections Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Meningococcal Infections Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Meningococcal Infections Vaccine Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Meningococcal Infections Vaccine Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Meningococcal Infections Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Meningococcal Infections Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Meningococcal Infections Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Meningococcal Infections Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Meningococcal Infections Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Meningococcal Infections Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Meningococcal Infections Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Meningococcal Infections Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Meningococcal Infections Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Meningococcal Infections Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Meningococcal Infections Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Meningococcal Infections Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 64. Creative Biolabs(USA) Company Details
Table 65. Creative Biolabs(USA) Business Overview
Table 66. Creative Biolabs(USA) Meningococcal Infections Vaccine Product
Table 67. Creative Biolabs(USA) Revenue in Meningococcal Infections Vaccine Business (2017-2022) & (US$ Million)
Table 68. Creative Biolabs(USA) Recent Developments
Table 69. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Company Details
Table 70. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Business Overview
Table 71. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Product
Table 72. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Revenue in Meningococcal Infections Vaccine Business (2017-2022) & (US$ Million)
Table 73. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Recent Developments
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Infections Vaccine Market Share by Type: 2021 VS 2028
Figure 2. Quadrivalent (Serogroups A, C, W-135, and Y) Features
Figure 3. Bivalent (Serogroups C and Y) Features
Figure 4. Serogroup A Features
Figure 5. Serogroup B Features
Figure 6. Serogroup X Features
Figure 7. Global Meningococcal Infections Vaccine Market Share by Application: 2021 VS 2028
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Meningococcal Infections Vaccine Report Years Considered
Figure 11. Global Meningococcal Infections Vaccine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Meningococcal Infections Vaccine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Meningococcal Infections Vaccine Market Share by Region: 2021 VS 2028
Figure 14. Global Meningococcal Infections Vaccine Market Share by Players in 2021
Figure 15. Global Top Meningococcal Infections Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Meningococcal Infections Vaccine Revenue in 2021
Figure 17. North America Meningococcal Infections Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Meningococcal Infections Vaccine Market Size Market Share by Type (2017-2028)
Figure 19. North America Meningococcal Infections Vaccine Market Size Market Share by Application (2017-2028)
Figure 20. North America Meningococcal Infections Vaccine Market Size Share by Country (2017-2028)
Figure 21. United States Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Meningococcal Infections Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Meningococcal Infections Vaccine Market Size Market Share by Type (2017-2028)
Figure 25. Europe Meningococcal Infections Vaccine Market Size Market Share by Application (2017-2028)
Figure 26. Europe Meningococcal Infections Vaccine Market Size Share by Country (2017-2028)
Figure 27. Germany Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Meningococcal Infections Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Meningococcal Infections Vaccine Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Meningococcal Infections Vaccine Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Meningococcal Infections Vaccine Market Size Share by Region (2017-2028)
Figure 37. China Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Meningococcal Infections Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Meningococcal Infections Vaccine Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Meningococcal Infections Vaccine Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Meningococcal Infections Vaccine Market Size Share by Country (2017-2028)
Figure 47. Mexico Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Meningococcal Infections Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Meningococcal Infections Vaccine Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Meningococcal Infections Vaccine Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Meningococcal Infections Vaccine Market Size Share by Country (2017-2028)
Figure 53. Turkey Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Meningococcal Infections Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Creative Biolabs(USA) Revenue Growth Rate in Meningococcal Infections Vaccine Business (2017-2022)
Figure 57. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Revenue Growth Rate in Meningococcal Infections Vaccine Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Industry Market Size
